Communiqués Earth Science Tech, Inc.

Actions

ETST

US2703111037

Produits pharmaceutiques

Marché Fermé - OTC Markets 21:58:21 04/06/2026			Varia. 5j.	Varia. 1 janv.
0,1700 ^USD	-1,11%		+84,58%	+29,77%

07/08	Earth Science Tech, Inc. publie ses résultats pour le premier trimestre clos le 30 juin 2026	CI
18/06	Earth Science Tech, Inc. publie ses résultats annuels pour l'exercice clos le 31 mars 2026	CI

Communiqués

12/08	Earth Science Tech, Inc. (ETST) Expands National Footprint with Strategic Acquisition of California Compounding Pharmacy, Meduvo LLC	AQ
07/08	Earth Science Tech, Inc. (ETST) Reports Fiscal First Quarter 2027 Financial Results for the Period Ended June 30, 2026	AQ
18/06	Earth Science Tech, Inc. Reports Fiscal Year-End Financial Results for March 31, 2026	AQ
10/06	Earth Science Tech, Inc. (ETST) Annual Shareholder Letter for FY Ended March 31, 2026	AQ
03/06	Earth Science Tech, Inc. (ETST) to Present at the Planet MicroCap Las Vegas 2026 Investor Conference Powered by MicroCapClub	AQ
24/03	Earth Science Tech, Inc. (ETST) Launches MyOnlineConsultation.com, Finalizing a Fully Vertically Integrated Telehealth and Pharmacy Ecosystem	AQ
17/02	Earth Science Tech, Inc. Announces Initiatives to Advance Public Company Strategy; Expects Approximately $1.4 Million in Annualized Savings and Fiscal 2026 Net Income Growth of More Than 40%, from $3.3 Million to $4.7 Million	AQ
17/02	Earth Science Tech, Inc. (ETST) Upgrades Audit Capabilities, Engages Semple, Marchal & Cooper, LLP as Independent PCAOB Auditor to Support Continued Expansion	AQ
17/02	Earth Science Tech, Inc. (ETST) Reports Third Fiscal Quarter 2026 Results	AQ
09/02	Earth Science Tech, Inc. (ETST), to Report Financial Results for Fiscal Third Quarter on February 17, 2026	AQ
23/01	IBN Initiates Coverage of Earth Science Tech Inc.	AQ
06/01	Earth Science Tech, Inc. (ETST) Issues Directive Industry Classification Update to SIC 2834; Formally Identifies as Pharmaceutical Entity Since 2022	AQ
05/01	Earth Science Tech, Inc. (ETST) Engages Hayden IR, Expanding Investor Relations Efforts to Support its Investor Outreach and Communications	AQ
15/12	Earth Science Tech, Inc. Receives FINRA Clearance on Form 211 to Initiate Quotations	AQ
12/11	Earth Science Tech, Inc. Reports Strong Q2 Fiscal 2025 Results	AQ
20/08/25	Earth Science Tech, Inc. Boosts Share Repurchase Program to $10 Million and Extends Authorization Through 2027	AQ
19/08/25	Earth Science Tech, Inc. Board of Directors Approves Reduction of Authorized Common Stock	AQ
08/08/25	Earth Science Tech, Inc. Reports 61% Asset Growth to $7.69 Million and $8.7 Million in First Quarter Revenue Following Foundational Quarter of Strategic Acquisitions	AQ
01/07/25	Earth Science Tech, Inc. Qualifies for and Joins New OTCID Tier	AQ
27/06/25	Earth Science Tech, Inc. Reports Fiscal Year-End Results for March 31, 2025, with Revenue Exceeding $33.1 Million and Net Profit of $3.2 Million	AQ
23/06/25	NASA Tech to Use Moonlight to Enhance Measurements from Space; NASA's Arcstone instrument will be the first mission exclusively dedicated to measuring moonlight, or lunar reflectance, from space as a way to calibrate and improve science data collected by Earth-viewing, in-orbit instruments.	AQ
06/05/25	Earth Science Tech, Inc. Annual Shareholder Letter FY Ending 03/31/2025	AQ
07/10/24	Earth Science Tech : Asset Transaction Form 8 K	PU
29/07/24	Earth Science Tech, Inc., Reports its June 30, 2024, Quarter Results, Recording Over $8.5M in Revenue and $1.07M in Net Profit	AQ
28/06/24	Earth Science Tech, Inc., Reports its March 31, 2024, Annual Results, Recording Over $11.9M in Revenue	AQ